UNSPSC 51373449: Codeine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373449 Codeine/phenylephrine/phenylpropanolamine is a Commodity code that covers pharmaceutical preparations containing these active ingredients, though state and local procurement activity under this specific code does not align cleanly with the pharmaceutical combinations its name denotes. Instead, the recent opportunities tagged to this code reflect a broader pattern of state and local health and correctional agencies procuring parenteral pharmaceutical products and overdose-reversal medications for clinical and public health use.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, soliciting parenteral products, services, and equipment for eight correctional facilities across the state, with responses due October 7, 2026. The scope includes parenteral nutrition solutions, intravenous solutions, and other parenteral products including controlled substances, with strict delivery requirements: TPN and PPN bags within 24 hours of order and other parenteral products within 8 hours. The contract runs November 26, 2026 through June 30, 2030, with DOC anticipating multiple award to up to three bidders per region. DOC encourages bidders to pursue small business, minority-owned business, women-owned business, and veteran-owned business participation through state certification. Separately, Seminole County, Florida issued IFB 60459723LAS in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building. These two opportunities illustrate the scope diversity under this code: state correctional health systems procuring compounded pharmaceuticals and delivery services, and county health departments procuring public health medications for opioid overdose response.

Recent activity concentrates in Washington and Florida, though the code shows limited breadth across jurisdictions. The Washington DOC opportunity represents substantial commitment to sustained pharmaceutical supply and services across a multi-facility system with stringent logistics requirements, while the Seminole County IFB reflects routine annual procurement of specific medications for community health. Issuing bodies include state correctional agencies and county public health departments. The code appears to capture state and local pharmaceutical procurement loosely; the opportunities present do not match the specific drug combination the code name specifies, signaling either misclassification in state procurement systems or use of this code as a catch-all for controlled and specialty pharmaceutical procurement.